ATE511T1 - N-alkylierte aminoalkohole und ihre salze, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate. - Google Patents

N-alkylierte aminoalkohole und ihre salze, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.

Info

Publication number
ATE511T1
ATE511T1 AT79101724T AT79101724T ATE511T1 AT E511 T1 ATE511 T1 AT E511T1 AT 79101724 T AT79101724 T AT 79101724T AT 79101724 T AT79101724 T AT 79101724T AT E511 T1 ATE511 T1 AT E511T1
Authority
AT
Austria
Prior art keywords
salts
preparation
pharmaceutical preparations
preparations containing
aminoalcohols
Prior art date
Application number
AT79101724T
Other languages
German (de)
English (en)
Inventor
Franz Dr. Ostermayer
Markus Dr. Zimmermann
Original Assignee
Ciba-Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba-Geigy Ag filed Critical Ciba-Geigy Ag
Application granted granted Critical
Publication of ATE511T1 publication Critical patent/ATE511T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
AT79101724T 1978-06-05 1979-06-01 N-alkylierte aminoalkohole und ihre salze, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate. ATE511T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH613678 1978-06-05
EP79101724A EP0005848B1 (fr) 1978-06-05 1979-06-01 Aminoalcools N-alcoylés et leurs sels, procédé pour leur préparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
ATE511T1 true ATE511T1 (de) 1982-01-15

Family

ID=4304840

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79101724T ATE511T1 (de) 1978-06-05 1979-06-01 N-alkylierte aminoalkohole und ihre salze, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.

Country Status (26)

Country Link
US (1) US4460580A (fr)
EP (1) EP0005848B1 (fr)
JP (1) JPS54163543A (fr)
KR (4) KR840000926B1 (fr)
AR (3) AR229951A1 (fr)
AT (1) ATE511T1 (fr)
AU (1) AU522483B2 (fr)
CA (1) CA1124241A (fr)
CY (1) CY1256A (fr)
DD (1) DD144050A5 (fr)
DE (1) DE2961669D1 (fr)
DK (1) DK229879A (fr)
ES (1) ES481238A1 (fr)
FI (1) FI791727A (fr)
GB (1) GB2026474B (fr)
GR (1) GR74057B (fr)
HK (1) HK15585A (fr)
HU (1) HU182019B (fr)
IL (1) IL57471A (fr)
MY (1) MY8500690A (fr)
NO (1) NO149034C (fr)
NZ (1) NZ190632A (fr)
PL (5) PL117158B1 (fr)
PT (1) PT69723A (fr)
SG (1) SG45884G (fr)
ZA (1) ZA792748B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
CA1152517A (fr) 1979-06-29 1983-08-23 Ian H. Coates Composes heterocycliques, procede de preparation et application
DD157796A5 (de) * 1979-12-04 1982-12-08 Ciba Geigy Ag Verfahren zur herstellung neuer derivate des 2-amino-aethanols
JPS5726653A (en) * 1980-05-09 1982-02-12 Ciba Geigy Ag Substituted phenyl ether
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
GR74992B (fr) * 1980-08-13 1984-07-12 Ciba Geigy Ag
JPS57185243A (en) * 1981-05-08 1982-11-15 Ciba Geigy Ag Substituted 2-aminoethanol
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
FR2543139B1 (fr) * 1983-03-22 1985-08-16 Cerm Cent Europ Rech Mauvernay Derives de (1-alcoxy 2-amino) ethyl pyridine ou pyrazine, leur preparation et leur application en therapeutique
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3608290A1 (de) * 1986-03-13 1987-09-24 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1287061C (fr) * 1986-06-27 1991-07-30 Roche Holding Ltd. Derives de pyridineethanolamines
GB8714901D0 (en) * 1986-07-23 1987-07-29 Ici Plc Amide derivatives
DE3627663A1 (de) * 1986-08-14 1988-03-03 Bayer Ag Heteroarylethylamine, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer bei tieren
US5108363A (en) * 1988-02-19 1992-04-28 Gensia Pharmaceuticals, Inc. Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
JPH0466934A (ja) * 1990-07-04 1992-03-03 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
JP2728564B2 (ja) * 1991-08-23 1998-03-18 エヌピーエス・ファーマシウティカルズ・インコーポレイテッド カルシウム受容体活性化分子
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US5208252A (en) * 1992-07-24 1993-05-04 Ortho Pharmaceutical Corporation Aminoethylthiophene derivatives
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
AU1533495A (en) * 1994-01-12 1995-08-01 Byk Nederland Bv Phenyl ethanol amine ethers and uses thereof as beta-adreno-receptor agonists
CZ290670B6 (cs) 1994-10-21 2002-09-11 Nps Pharmaceuticals, Inc. Sloučeniny modulující receptory anorganických iontů a farmaceutický prostředek, který je obsahuje
PT907631E (pt) * 1996-05-01 2003-10-31 Nps Pharma Inc Compostos inorganicos activos como receptores de ioes
KR100380520B1 (ko) * 2000-09-08 2003-04-23 한국화학연구원 피리딘을 포함한 β-아미노알코올 유도체
WO2003090251A1 (fr) * 2002-04-22 2003-10-30 Koninklijke Philips Electronics N.V. Ecran luminescent
US7538141B2 (en) * 2004-03-23 2009-05-26 Alan Daniel Brown Compounds for the treatment of diseases
JP2013522195A (ja) * 2010-03-08 2013-06-13 ザ ユニバーシティー オブ テネシー リサーチ ファウンデーション ベータアドレナリン受容体アゴニスト及びその使用
ITMI20122221A1 (it) * 2012-12-21 2014-06-22 C4T S C A R L Nuovi composti del 2,3-diidro-4h-1,3-benzossazin-4-one, metodo per prepararli e forma farmaceutica che li comprende
CN104008939B (zh) * 2014-06-19 2016-05-11 苏州普京真空技术有限公司 一种耐用电子枪灯丝
USD954933S1 (en) 2018-06-01 2022-06-14 Chiaro Technology Limited Breast pump accessory

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1178400A (en) * 1966-12-13 1970-01-21 Delalande Sa Nitrogen Substituted Amines and their process of Preparation.
DE1543538A1 (de) * 1966-12-30 1976-02-05 Degussa Verfahren zur herstellung neuer heterocyclischer aminoalkohole
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
GB1398738A (en) * 1972-12-05 1975-06-25 Pfizer Ltd Propanolamine derivatives
US4082772A (en) * 1975-04-18 1978-04-04 American Home Products Corporation Thiophene ethanolamines
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines

Also Published As

Publication number Publication date
GB2026474B (en) 1982-07-14
IL57471A (en) 1982-11-30
KR830000681A (ko) 1983-04-18
HK15585A (en) 1985-03-15
DE2961669D1 (en) 1982-02-18
PL216090A1 (fr) 1980-03-24
NO791841L (no) 1979-12-06
KR830000680A (ko) 1983-04-18
US4460580A (en) 1984-07-17
PL117155B1 (en) 1981-07-31
JPS54163543A (en) 1979-12-26
PL116612B1 (en) 1981-06-30
HU182019B (en) 1983-12-28
AU522483B2 (en) 1982-06-10
CA1124241A (fr) 1982-05-25
PL117158B1 (en) 1981-07-31
NZ190632A (en) 1984-07-06
DD144050A5 (de) 1980-09-24
EP0005848A1 (fr) 1979-12-12
NO149034C (no) 1984-02-01
MY8500690A (en) 1985-12-31
AR229581A1 (es) 1983-09-30
AR229022A1 (es) 1983-05-31
EP0005848B1 (fr) 1981-12-30
CY1256A (en) 1984-11-23
AR229951A1 (es) 1984-01-31
PT69723A (de) 1979-07-01
GB2026474A (en) 1980-02-06
FI791727A (fi) 1979-12-06
ZA792748B (en) 1980-06-25
KR840000926B1 (ko) 1984-06-29
NO149034B (no) 1983-10-24
ES481238A1 (es) 1980-02-16
GR74057B (fr) 1984-06-06
PL116597B1 (en) 1981-06-30
PL116529B1 (en) 1981-06-30
KR830000679A (ko) 1983-04-18
SG45884G (en) 1985-03-08
DK229879A (da) 1979-12-06
AU4773679A (en) 1979-12-13

Similar Documents

Publication Publication Date Title
ATE511T1 (de) N-alkylierte aminoalkohole und ihre salze, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
ATE46900T1 (de) Phenylethanolaminotetraline, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3786390D1 (de) Arylaminopyrimidin-derivate, verfahren zu deren herstellung und diese als wirksamen stoff enthaltende insektizide, akarizide und fungizide.
DE3851986D1 (de) Aminsäure-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
ATE6934T1 (de) Sulfonylharnstoffe, verfahren zu ihrer herstellung und pharmazeutische praeparate enthaltend diese verbindungen.
ATE6030T1 (de) Pankreatin-pellets, verfahren zu deren herstellung und diese pellets enthaltende arzneimittel.
DE3852145D1 (de) Indolderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, die diese enthalten.
LU79937A1 (de) Neue 1-acyl-2-cyanaziridine,verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen
ATE6859T1 (de) Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE27451T1 (de) Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung.
DE2961804D1 (en) N-(3-benzoylpropyl)-spiro-(dihydrobenzofuranpiperidines and -pyrrolidines), derivatives thereof, methods for their preparation and their use for medicines
DE3766299D1 (de) 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE9895T1 (de) 1-phenyl-2-cyclohexen-1-alkylamin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
ATE10634T1 (de) Pyrazoloindazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung.
ATE67210T1 (de) Androstane-17-beta-carbonsaeureester, verfahren zu deren herstellung und pharmazeutische praeparate die diese enthalten.
DE3852332D1 (de) 4-Thiochinazolin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellungen.
ATE10094T1 (de) 3,4-bis-substituierte 1,2,5-oxadiazol-2-oxide, verfahren zu ihrer herstellung, und sie enthaltende pharmazeutische zubereitungen.
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
ATE4206T1 (de) Neue morpholinderivate, verfahren zu deren herstellung, diese derivate enthaltende pharmazeutische praeparate.
ATE2894T1 (de) Pyrrolidin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
ATE57935T1 (de) 16,17-acetalsubstituierte pregnan-21-saeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
DE3380989D1 (de) 2-aminobenzosaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen.
ATE9470T1 (de) Indolessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel.
DD128615A5 (de) Neue aziridin-derivate,verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
ATE2673T1 (de) Phenothiazinderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification